Showing results (791-800 of 1,036) with videos related to
Sort By:
Pageof 104
ALTEX|March 26, 2014
Controversial role of gamma-glutamyl transferase activity in cisplatin nephrotoxicityLukas Fliedl, Matthias Wieser, Gabriele Manhart, et al.ALTEX|October 18, 2018
Chemical hazard prediction and hypothesis testing using quantitative adverse outcome pathwaysEdward J Perkins, Kalyan Gayen, Jason E Shoemaker, et al.ALTEX|June 1, 2011
A critique of the EC's expert (draft) reports on the status of alternatives for cosmetics testing to meet the 2013 deadlineKaty Taylor, Carlotta Casalegno, Wolfgang StengelALTEX|October 14, 2011
Can case study approaches speed implementation of the NRC report: "Toxicity Testing in the 21st Century: A Vision and a Strategy?"Melvin E Andersen, Harvey J Clewell, Paul L Carmichael, et al.ALTEX|October 14, 2011
An expert consortium review of the EC-commissioned report "alternative (Non-Animal) methods for cosmetics testing: current status and future prospects - 2010"Thomas Hartung, Bas J Blaauboer, Sieto Bosgra, et al.ALTEX|December 2, 2011
A replacement-first approach to toxicity testing is necessary to successfully reauthorize TSCAPaul A Locke, D Bruce MyersALTEX|December 2, 2011
The automated FADU-assay, a potential high-throughput in vitro method for early screening of DNA breakageMaría Moreno-Villanueva, Tobias Eltze, Dirk Dressler, et al.ALTEX|July 1, 2009
The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammationAnja Henn, Søren Lund, Maj Hedtjärn, et al.ALTEX|July 1, 2009
Quantitation of angiogenesis and antiangiogenesis in vivo, ex vivo and in vitro - an overviewMahtab Bahramsoltani, Johanna Plendl, Pawel Janczyk, et al.ALTEX|October 22, 2021
Animal metrics: Tracking contributions of new approach methods to reduced animal useM Sue Marty, Amanda K Andrus, Katherine A GroffPageof 104